NicolaBrunetti-PierriMD

Clinical Biochemical Genetics, Clinical Genetics, Pediatric Medical Genetics

Associate Professor

Dr. Brunetti-Pierri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2 Greenway Plz
Ste 900
Houston, TX 77046
Phone+1 713-798-1750

Fax+1 713-798-1144

Use of Phenylbutyrate Therapy for Patients With Pyruvate Dehydrogenase Complex Deficiency. Start of enrollment: 2018 Oct 01
Completed
Phase 2
Gene Therapy for Severe Crigler Najjar Syndrome Start of enrollment: 2018 Mar 19
Recruiting
Not Applicable
Roles: Principal Investigator

PubMed

1690 citations
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Daniel J. Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli
Autophagy. 2021-02-08
29 citations
Alpha-1 antitrypsin deficiency: a re-surfacing adult liver disorder
Malin Fromme, Carolin V. Schneider, Christian Trautwein, Nicola Brunetti-Pierri, Pavel Strnad
Journal of Hepatology. 2021-11-27
84 citations
DUF1220-domain copy number implicated in human brain-size pathology and evolution.
Laura Dumas, Majesta O'Bleness, Jonathan M. Davis, C. Michael Dickens, Nathan Anderson
American Journal of Human Genetics. 2012-09-07

Adeno Associated Virus (AAV) Gene Therapy For Mucopolysaccharidosis Type IINational Center For Research Resources2010–2011
Hdad-Mediated Gene Therapy For Hemophilia BNational Heart, Lung, And Blood Institute2009
Adeno Associated Virus (AAV) Gene Therapy For Mucopolysaccharidosis Type IINational Center For Research Resources2008–2009
Hdad-Mediated Gene Therapy For Hemophilia BNational Heart, Lung, And Blood Institute2007–2008